Expression studies conducted in vitro and in Escherichia coli led to the identification of a protease from rabbit hemorrhagic disease virus (RHDV) picornaviruses (32) . Similar propositions were made for feline calicivirus (FCV) and Norwalk virus (6, 20, 34) .
Expression studies conducted in vitro and in Escherichia coli led to the identification of a protease from rabbit hemorrhagic disease virus (RHDV) . The gene coding for this protease was found to be located in the central part of the genome preceding the putative RNA polymerase gene. It was demonstrated that the protease specifically cuts RHDV polyprotein substrates both in cis and in trans. Site-directed mutagenesis experiments revealed that the RHDV protease closely resembles the 3C proteases of picornaviruses with respect to the amino acids directly involved in the catalytic activity as well as to the role played by histidine as part of the substrate binding pocket.
Rabbit hemorrhagic disease virus (RHDV) has been recently assigned to the Caliciviridae family (35, 38) . The 7,437-nucleotide (nt) viral genome consists of single-stranded RNA of positive polarity and is packaged in a small icosahedral capsid of about 40 nm in diameter; in addition to the genomic RNA, an abundant subgenomic RNA of 2.2 kb in length, which is coterminal with the 3' end of the viral genome, was detected in livers of infected animals and in purified viral particles (32, 33) . The main structural component of RHDV is a single protein species of 60 kDa (VP60).
Because of the failure to grow the virus in tissue culture, studies on RHDV have relied on the experimental infection of rabbits and on in vitro methods. The genomic RNA of RHDV has been cloned as cDNA and completely sequenced. It contains a long open reading frame (ORF1) which spans 7 kb of the genome and has a coding capacity for a hypothetical polyprotein of 257 kDa (32) . According to the results from sequence analysis studies and mapping experiments, the genome organization of RHDV is similar to that of other caliciviruses characterized to date (6, 20) . The nonstructural genes are clustered in the 5' region, followed by the gene for the capsid protein in the 3' region. It is noteworthy that in the case of RHDV, ORF1 contains the nonstructural and the capsid protein genes, while in other caliciviruses, the capsid protein is encoded by a separate ORF. For RHDV, it is therefore possible that the synthesis of VP60 follows two distinct pathways: one through processing of the polyprotein precursor translated from the genomic RNA, the second by translation of the subgenomic RNA (33, 37) .
As for other positive-strand RNA viruses, e.g., picornaviruses, the generation of mature RHDV proteins requires that proteolytic cleavages be effected at specific sites of the large polyprotein translated from the viral genomic RNA. For nonenveloped positive-strand RNA viruses, polyprotein processing is usually carried out by viral proteases. Computer analysis of the RHDV sequence showed that a region located immediately upstream of the putative RNA polymerase in the RHDV polyprotein may correspond to the 3C proteases of picornaviruses (32) . Similar propositions were made for feline calicivirus (FCV) and Norwalk virus (6, 20, 34) .
Picornavirus 3C proteases belong to a large family of trypsin-like enzymes which, according to computer predictions, share a common three-dimensional structure and a few wellconserved residues. Among these, the so-called catalytic triad, which for trypsin comprises serine as the nucleophilic group, is a common signature of the family (4) . In many viral proteases, the role of serine is taken over by a cysteine residue. In the present study, in vitro transcription and translation experiments, as well as bacterial expression studies, were used to identify and characterize the RHDV protease.
MATERUILS AND METHODS
Virus purification and RNA extraction. The cDNA fragments used in this work were cloned from two independent RHDV isolates: a German isolate and an Italian one (RHDV BS89). Both isolates were completely sequenced (32, 38a) .
RHDV particles were obtained from liver homogenates of experimentally infected rabbits and purified as previously described (32) . Viral RNA for in vitro transcription was extracted from intact purified virions treated with micrococcal nuclease (20 min at room temperature [RT]) to remove contaminating cellular nucleic acids; micrococcal nuclease was then blocked by addition of EGTA (20 mM), and proteins were digested by incubation for 30 min at 50°C with proteinase K (150 ,ug/ml; Boehringer) in the presence of 0.5% sodium dodecyl sulfate (SDS). Viral RNA was extracted twice with phenol and phenol-chloroform and concentrated by ethanol precipitation (39) .
Subcloning and sequencing. The RHDV cDNA plasmid clones were obtained by in vivo excision from lambda ZAPII (Stratagene) clones, isolated by hybridization to a 32P-labeled cDNA probe or by expression screening with anti-RHDV monoclonal antibodies (32, 38a) as described by Sambrook et al. (39) . Fractionation of restriction enzyme-digested DNA on agarose gels, DNA purification from agarose slices with a Gene Clean kit (Bio 101), and ligation into pBS KSII (Stratagene) followed by transformation of frozen Escherichia coli XL1-Blue competent cells (39) 9 ,000 rpm for 10 min. The bacterial lysates were then subjected to ultracentrifugation (1OOS), and the supernatant was assayed for the presence of protease activity.
Site-directed mutagenesis. Sequential PCRs with the mutagenic oligonucleotide primers 5'-CGGTGAC£GGTGGGCT GCCGT-3' (direct) and 5'-CAGCCCACCGTCACCGTGA GT-3' (reverse) were used as described by Cormack (9) to introduce the C1212G substitution. All other mutants were constructed by the method of Kunkel et al. (25) , using a Muta-Gene Phagemid in vitro mutagenesis kit (Bio-Rad) as described by the manufacturer. The template DNA for the mutagenesis, uracil-containing single-stranded DNA, was ob- (Fig. 1B) . Instead, the gel showed two proteins of about 60 and 80 kDa. On the basis of its exact comigration with VP60 from purified virus and of its recognition by a monoclonal antibody, the 60-kDa protein corresponds to the VP60 protein (Fig. 1B, lanes 2 and 4) (Fig.  1B, lanes 1 and 3) .
To assay whether the N-terminal region of the polyprotein encoded by p672 was actually involved in the observed processing of the polyprotein, plasmid p672 was split into two subclones: pP20, which codes for 355 aa at the N terminus of the p672 ORF, and pP7, which comprises the genes for the putative RNA polymerase and for VP60. In contrast to p672, translation of pP7 RNA yielded a band corresponding to a polyprotein of the expected size (102 kDa; Fig. 1C, lane 1) . Therefore, the 355 aa missing from clone pP7 were required for efficient processing at the boundary between the RNA polymerase and VP60, suggesting that the respective part of the polyprotein corresponds to a viral protease. Further evidence for this assumption was sought by cotranslation of the pP7 and pP20 RNAs, which resulted in a sharp increase of the amount of mature VP60, while the amount of the 102-kDa polyprotein was reduced in parallel (Fig. 1C, lane 2) . Additional bands are visible in Fig. 1C (Fig. 2B, lane 3) . Since the molecular masses of the two proteins account for the size of the 50.9-kDa fusion protein, Western blot (immunoblot) experiments were performed to confirm their identity. The 21-kDa polypeptide is the N-terminal fragment, as demonstrated by specific reaction with an anti-MS2 polymerase serum (Fig. 2B, lanes 1 and 2) . In lane 2, a faint band of about 38 kDa is also visible and may constitute an alternative cleavage product of the 50.9-kDa protein; it was not further studied because of its very low amount. The reactivity of the 30-kDa product with a polyclonal serum raised against a polypeptide corresponding to the RHDV ORFi from aa 1172 to 1331 indicated that it derives from the C-terminal region of the pEX01 construct (data not shown). Taking into account the fact that the pEX01 insert includes the entire cDNA sequence of pP20, which could restore processing of the RHDV polyprotein after in vitro translation, one can conclude that the 30-kDa polypeptide contains the protease domain and is sufficient for specific proteolytic cleavage.
The ability of the bacterially expressed protease to specifically cut polyprotein substrates in trans was determined by using crude lysates of E. coli XL1-Blue cells harboring plasmid pMAL-PRT1 ( Fig. 2A) as the source of proteolytic activity. This expression system yielded about 60% of the protease in a soluble form, as demonstrated by Western blotting of the cytoplasmic and insoluble fractions after cell lysis (data not shown). The substrate for the protease was synthesized from pMB11 ( Fig. 2A) , a plasmid containing a portion of the RHDV ORF1 from amino acids 1650 to 2344 that includes 116 C-terminal amino acids of the putative RNA polymerase and the entire VP60 sequence but no protease domain. The in vitro-labeled 73.7-kDa precursor from pMB11 was cut at the junction between the RNA polymerase and the capsid protein only upon addition of the bacterial lysate expressing the protease (Fig. 2C) . As a result of this cut, the precursor band disappeared and a band corresponding to VP60 became detectable (Fig. 2C, lane 2) ; the other product of the proteolytic reaction, an N-terminal peptide of about 13 kDa, was also detected (data not shown). Processing of the 73.7-kDa protein was not due to experimental artifacts, as demonstrated by incubation with extract of bacteria (Fig. 2C, lane 3) that harbor a pMAL-PRT1 expressing an inactive protease (by mutation of Cys-1212 to Gly; see below).
It should be noted that the processing observed after expression of pEX01 occurred at the N terminus of the protease domain, while the in vitro translation experiments as well as cleavage in trans by the pMAL-PRT1 product demonstrated cleavage at the boundary between the putative RNA polymerase and VP60.
Mutagenesis of the RHDV protease. Although scarcely similar with respect to primary sequence, the large family of trypsin-like proteases, to which picornavirus 3C proteases belong, can be modeled to reveal common structural features (3, 14) . Four similarity boxes have been identified in these proteins (4) (Fig. 3) ; the amino acids constituting the so-called catalytic triad, in the case of picornavirus proteases His, Asp/Glu, and Cys, are distributed in the first three boxes, while the fourth box is thought to participate in the structure of the substrate binding pocket. The key role of these amino acids has been demonstrated in several instances by mutagenesis studies (8, 15, 22) . The sequence of the RHDV protease region was aligned with the putative protease sequences of two caliciviruses (FCV and Norwalk virus) and with two well-characterized proteases from poliovirus and human rhinovirus (Fig. 3) . (32) are shown. In plasmid pEX01, transcription from the lambda left promoter (PL) directs the synthesis of a fusion protein comprising 110 aa from vector sequences and 349 aa (38.7 kDa) from the RHDV ORF1. In plasmid pMAL-PRT1, the fusion protein includes 389 residues of the maltose-binding protein (MBP), 266 residues from the RHDV ORF1, and a 9-kDa a fragment of ,B-galactosidase (13-gal); in this case, transcription starts from an hybrid tryptophan-lacZ promoter (P tac). Plasmid pMB11 codes for a 73.7-kDa polyprotein spanning the carboxy-terminal part of the RHDV RNA polymerase and the entire capsid protein gene from nt 5305 to 5307 (corresponding to the translation start codon of the subgenomic RNA) to the stop codon at nt 7042 to 7044 of the RHDV cDNA sequence. In vitro transcription is driven by the T7 promoter; translation starts at an AUG codon near the BglII site. The arrowheads point to the approximate positions of the protease target sites. The sizes of the expected fusion protein and of the products after proteolytic cuts are also reported for pEX01 and pMB11. Only a few residues, mostly clustered within the similarity boxes, are well conserved between the calicivirus and the picornavirus sequences. On the basis of their conservation and relative positions along the sequence, residues His-1135, Asp-1152, Asp-1175, Cys-1212, and His-1227, were selected for replacement by oligonucleotide-specific site-directed mutagenesis, thus generating a set of single amino acid substitution mutants.
We took advantage of the ability of the protease to cut the fusion protein derived from expression of pEX01 in E. coli to compare the activity of the wild-type enzyme versus a set of pEX01 derivatives carrying the desired mutation. The recombinant proteins were purified from inclusion bodies, separated by gel electrophoresis, and stained by Coomassie blue (Fig. 4) . A replicate of this gel was also analyzed by Western blotting to confirm the identity of each product (data not shown).
The first amino acid to be replaced was Cys-1212 because Cys distinguishes the viral 3C-like proteases from other members of the trypsin family, which contain Ser as one of the catalytic residues. Replacement of Cys-1212 with Gly completely abolished proteolytic activity in E. coli (Fig. 4, lane 4) . On the other hand, replacement with Ser, which maintains the nucleophilic character of Cys but does not have similar structural functions such as the ability to form disulfide bridges, yielded a protease with relatively high activity corresponding to about one-half of the activity of the wild-type protease (lane 3); these data and the good degree of conservation of the amino acids immediately surrounding Cys-1212 strongly suggest that Cys-1212 is an essential constituent of the catalytic site of the RHDV protease.
The trypsin-like proteases characterized so far invariably include His in the catalytic triad. We mutated His-1135 because its position and the sequence context made it a more likely candidate than two other His residues, at positions 1116 and 1124, respectively. Replacement of His-1135 by Asn (Fig.  4 , lane 5) demonstrated that this residue is crucial for proteolytic activity.
Two amino acids that could fulfill the role of the acidic residue of the catalytic triad were identified: Asp-1152 and Asp-1175. Both residues were mutated independently to Gly (different size and different chemistry with respect to Asp), Asn (similar size but different chemistry), and Glu (different size but similar chemistry). The Asp-to-Gly mutants completely lost activity in both cases (Fig. 4, lanes 8 and 11) . However, the results of the other substitutions were strikingly different according to which position was involved: the Asp-toGlu mutation yielded a protease with close to wild-type activity when the mutation was at position 1152, but very little activity G  FIG. 3 . Alignment of the RHDV protease region (aa 108 through 1244 of ORF1) with similar sequences of FCV (6) and Norwalk virus (NWV) (27) and the 3C proteases of poliovirus type 2 (PV2) (28) and human rhinovirus 14 (HRV14) (41). The letters above the alignment indicate the amino acids that were mutated in this study. Four similarity boxes highlight structural motifs common to viral and cellular proteases as described by Bazan and Fletterick (4). The settings used to run the analysis programs and any modification of the original output are described in Materials and Methods. Cons., consensus.
was retained after introduction of the same change at position 1175 (compare lanes 7 and 10). In contrast, the substitution of Asp by Asn, while giving a nonfunctional protease if position 1152 was involved, yielded a nearly normal activity for the position 1175 mutant (lanes 6 and 9). These data indicate that an acidic residue is required at position 1152 but not at position 1175.
Some amino acids in the proximity of the active nucleophile (Cys or Ser) of the trypsin-like proteases are known to participate in the substrate binding pocket (box 4 in Fig. 3 ). In particular, a His residue is invariably present within this box in all viral proteases that cleave after Glu or Gln. In the case of the RHDV protease, the conserved His is probably represented by His-1227. Mutagenesis of this amino acid to either Asn or Leu (lanes 12 and 13) led to complete loss of proteolytic activity. This finding is consistent with the notion that His-1227 is directly involved in substrate binding. However, it cannot be ruled out that protease inactivation by the His-1227 mutation is the consequence of a change in protein structure.
DISCUSSION
The genome organization of RHDV implies that mature viral proteins are generated through specific proteolytic cuts of a large precursor. In other plus-strand RNA viruses, processing is usually mediated by one or more highly specific proteases. Therefore, the existence of a protease gene in the genome of RHDV was suspected. Amino acid sequence alignments provided the first indication for a protease that exhibits similarity to 3C proteases of picornaviruses and is encoded in the central part of the genome in RHDV and other caliciviruses (20, 27, 32, 34) .
In this report, we demonstrate that the predicted protease of RHDV is functional and is able to cut polyprotein substrates in cis as well as in trans. The location of the protease gene in front of the putative RNA polymerase gene is similar to that found for 3C proteases of picornaviruses and related proteases of several plus-strand RNA viruses of plants (12, 24) . By this criterion, caliciviruses are members of the supergroup I of plus-strand RNA viruses, which includes picorna-, como-, nepo-, and potyviruses.
A large number of viral proteases, including 3C and 2A proteases of picornaviruses, are thought to be homologous to the trypsin family of serine proteases. This conclusion is based on molecular modeling studies and on amino acid sequence alignments that identify conserved residues proposed to correspond to the catalytic triad of cellular serine proteases (3, 14) and has been recently supported by resolution of the crystal structure of the hepatitis A virus 3C protease (1) . According to the alignment presented here, the putative catalytic residues identified in picornavirus proteases 3C and 2A (15, 18, 22, 40 The prediction of His-1135, Asp-1152, and Cys-1212 as constituents of the catalytic triad of the RHDV protease is strongly supported by the mutagenesis analysis. Cys-1212 very likely represents the nucleophilic residue because substitution by Gly abolished the proteolytic activity, whereas substitution by Ser, which acts as the nucleophile in trypsin and other proteases, yielded a mutant protein with a good degree of activity. Replacement of Cys by Ser has been performed in several other viral proteases. In some cases, activity was observed after in vitro translation of the mutant protease (13, 29, 30) , but no activity was detected after expression in E. coli (8, 15, 19) and in assays for cleavage in trans of peptides or synthetic polyprotein fragments as substrates (15) . This is the first report of a Cys-to-Ser mutant protease that retains activity after expression in E. coli.
The position relative to the N terminus and the sequence context of His-1135 made it the most likely candidate to be homologous to (Fig. 3, box 1 ) and to His-20 ( Fig. 5 ) of 3C and 2A picornavirus proteases, respectively, a prediction supported by the functional inactivation of the enzyme obtained after mutation of His-1135 to Asn.
Finally, Asp-1152 most likely represents the acidic residue of the putative catalytic triad, because of three substitutions at position 1152, only Glu had no effect on protease activity, while both Gly and Asn behaved as null mutations. Similar results were obtained with poliovirus 3C protease and tobacco etch virus 49-kDa protease (13, 15) . The homology of 3C proteases with cellular serine proteases has been suggested by two independent models that differ in the prediction of the acidic amino acid of the catalytic triad: Glu-71 in the poliovirus 3C protease according to Gorbalenya et al. (14) and Asp-85 according to Bazan and Fletterick (3) . No conserved acidic residue is present in the RHDV and FCV proteases at the position corresponding to Asp-85 of the poliovirus 3C protease. Our alignment and the mutagenesis data are thus consistent with the model of Gorbalenya et al. (14) . A similar conclusion has been reached for the 3C protease of poliovirus (15) , the 3C-like protease of grapevine fanleaf nepovirus (30) , and the 24-kDa protease of cowpea mosaic virus (10) .
Previous alignments of the calicivirus protease domains and 3C proteases of picornaviruses identified the conserved cysteine and a conserved histidine that is thought to be part of the substrate binding pocket (20, 32, 34) but not the conserved histidine and acidic amino acid of the catalytic triad. The failure to identify the latter amino acids can be explained by the low overall homology as well as by the shorter size of the RHDV protease domain. In RHDV, the spacing between His-1135 and Asp-1152 (17 aa) is very close to the distance between His-20 and Asp-38 of the poliovirus 2A protease (18 aa) but considerably shorter than the distance between His-40 and Glu-71 (31 aa) of the poliovirus 3C protease. The distance between Asp-1152 and Cys-1212 (60 aa) is even shorter than the distance between the corresponding Asp-38 and Cys-109 (71 aa) of the 2A protease; the homologous residues of 3C protease (Glu-71 and Cys-147) are separated by 76 residues. Therefore, the size and possibly the structure of the RHDV protease are more similar to those of 2A proteases (Fig. 5 ) than to those of 3C proteases. On the other hand, the protease domain of Norwalk virus approaches 3C proteases in size. Our expression studies showed that the protease retains activity if the putative polymerase domain is removed. It should be noted, however, that we never detected processing at the protease-polymerase boundary, an event observed for picornaviruses when similar constructs were used (17, 36) . To clarify this issue further, functional studies and size estimation of the protease in infected cells are needed.
A survey of the 3C-like protease target sites shows that the P1 position is usually occupied by Gln or Glu, a requirement attributed to the interaction with a conserved His in the substrate binding pocket. A notable exception is represented by the 3C-like proteases of nepoviruses, in which His is replaced by Leu, and it has been shown that these proteases cleave after Arg, Cys, or Gly (5, 31). Similarly, 2A proteases which cleave after Tyr, Ala, Thr, or Val (16, 23, 44) lack the conserved histidine and instead contain a valine, leucine, or isoleucine at the corresponding position within the binding pocket. For RHDV, the putative binding pocket contains a His at the corresponding position (His-1227); substitution with either Leu or Asn abolished the activity of the enzyme, suggesting that His-1227 is indeed involved in binding to the substrate and that the RHDV protease should cut afte,r Gln or Glu. In FCV, a related calicivirus, N-terminal sequence determination of the capsid protein which is generated by a proteolytic processing supports the prediction that the P1 target of the protease is either Gln or Glu (7) . According to these considerations, the dipeptide Glu-Gly at positions 1108 and 1109 was chosen as the N-terminal boundary of the RHDV protease domain in the alignments reported here. Similarly, two candidate cleavage sites exist at the polymerase-VP60 boundary: Glu-Gly at positions 1767 and 1768 and Gln-Gly at positions 1775 and 1776; because of their proximity to each other, it was not possible to discriminate between them on the basis of the relative molecular weights of the proteolytic products.
Recently Parra et al. (37) performed partial sequencing of cyanogen bromide-derived peptides from purified RHDV and (28) and human rhinovirus 14 (HRV14) (41) . Four similarity boxes highlight structural motifs common to viral and animal proteases as described by Bazan and Fletterick (3) . The sequences were aligned with the program Pileup, using the following settings: gap weight at 2 and gap length weight at 0. 1. suggested that the VP60 incorporated into virions originates from translation of subgenomic but not genomic RNA. The experiments reported here demonstrate that at least in vitro, the capsid protein can also be generated by a protease mediated cut of the ORF1 product at the polymerase-VP60 boundary. The function of this additional pathway for expression of the RHDV capsid protein remains to be established.
